Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; hypromellose; purified water; titanium dioxide; macrogol 8000; purified talc; iron oxide red - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; purified water; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; purified water; hypromellose; titanium dioxide; macrogol 8000; purified talc; iron oxide red - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; purified water; maize starch; hypromellose; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Malta - English - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - solifenacin succinate - film-coated tablet - solifenacin succinate 5 mg - urologicals

Malta - English - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - solifenacin succinate - film-coated tablet - solifenacin succinate 10 mg - urologicals

Canada - English - Health Canada

jamp pharma corporation - solifenacin succinate - tablet - 5mg - solifenacin succinate 5mg - antimuscarinics

Canada - English - Health Canada

jamp pharma corporation - solifenacin succinate - tablet - 10mg - solifenacin succinate 10mg - antimuscarinics

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: maize starch; purified talc; lactose monohydrate; hypromellose; magnesium stearate; titanium dioxide; propylene glycol; iron oxide yellow - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - solifenacin succinate 10mg;   - film coated tablet - 10 mg - active: solifenacin succinate 10mg   excipient: hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate maize starch propylene glycol purified talc titanium dioxide - solifenacin viatris is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent microurination, and/or urge incontinence.